321
Participants
Start Date
June 15, 2015
Primary Completion Date
November 7, 2017
Study Completion Date
November 7, 2017
Dapagliflozin 10 mg
Tablets administered orally once daily for 24 weeks. Randomization will be stratified by pre-enrolment anti-hyperglycemic therapy
Matching Placebo for Dapagliflozin
Matching Placebo for Dapagliflozin tablets administered orally once daily for 24 weeks
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Botevgrad
Research Site, Kyustendil
Research Site, Blagoevgrad
Research Site, Kozloduy
Research Site, Stara Zagora
Research Site, Stockholm
Research Site, A Coruña
Research Site, Ferrol
Research Site, Manassas
Research Site, Milan
Research Site, Bergamo
Research Site, Lleida
Research Site, Chapel Hill
Research Site, Madrid
Research Site, Madrid
Research Site, Pozuelo de Alarcón
Research Site, Málaga
Research Site, Miami
Research Site, Pembroke Pines
Research Site, Miami
Research Site, Miami Springs
Research Site, Padua
Research Site, Huntsville
Research Site, Chattanooga
Research Site, La Laguna (Tenerife)
Research Site, Jackson
Research Site, Louisville
Research Site, Brownsburg
Research Site, Flint
Research Site, Pisa
Research Site, Chicago
Research Site, Chesterfield
Research Site, Kansas City
Research Site, Chieti Scalo
Research Site, Bari
Research Site, San Giovanni Rotondo
Research Site, Monroe
Research Site, Houston
Research Site, San Antonio
Research Site, San Antonio
Research Site, Napoli
Research Site, Burbank
Research Site, Chula Vista
Research Site, Huntington Beach
Research Site, Newport Beach
Research Site, Concord
Research Site, Los Gatos
Research Site, Fullerton
Research Site, Salinas
Research Site, Red Deer
Research Site, Surrey
Research Site, Halifax
Research Site, Brampton
Research Site, Cambridge
Research Site, Concord
Research Site, Courtice
Research Site, Etobicoke
Research Site, Greater Sudbury
Research Site, Guelph
Research Site, London
Research Site, North York
Research Site, Oakville
Research Site, Toronto
Research Site, Toronto
Research Site, Québec
Research Site, Saskatoon
Research Site, Cheb
Research Site, Hořovice
Research Site, Krnov
Research Site, Kutná Hora
Research Site, Ostrava
Research Site, Prague
Research Site, Praha Klanovice
Research Site, Bielsko-Biala
Research Site, Bydgoszcz
Research Site, Lodz
Research Site, Mrągowo
Research Site, Ostrowiec Świętokrzyski
Research Site, Tczew
Research Site, Wroclaw
Research Site, Alicante
Research Site, Gothenburg
Research Site, Lund
Research Site, Stockholm
Lead Sponsor
AstraZeneca
INDUSTRY